You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 202043438
Nov 2020491491259
Dec 202020220260
Jan 202116916947
Feb 202115515552
Mar 202118918950
Apr 202118518538
May 202116016053
Jun 202110010035
Jul 2021626238
Aug 2021737331
Sep 2021929246
Oct 202110110259
Nov 202126725439
Dec 202129928533
Jan 2022788852
Feb 2022505231
Mar 2022798552
Apr 202217217851
May 202216817547
Jun 202214015453
Jul 2022717438
Aug 2022828859
Sep 2022777835
Oct 2022717558
Nov 2022707138
Dec 2022575719
Jan 2023828214
Feb 2023868818
Mar 2023585940
Apr 2023444653
May 2023707230
Jun 2023535455
Jul 2023515227
Aug 2023717137
Sep 2023626220
Oct 2023555528
Nov 2023777739
Dec 2023656618
Jan 2024545539
Feb 2024737330
Mar 2024108111114
Total471247601943